Afya Ltd

Chart & Performance

D1W1MN

P/E

22.45

P/S

3.02

EPS

4.28

Div Yield, %

0.00%

Shrs. gr., 5y

0.64%

Rev. gr., 5y

53.82%

Revenues

2.88b

+23.48%

Net income

386m

+3.41%

CFO

1.04b

+23.67%

Earnings

Jun 05, 2025

Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

URL

https://www.afya.com.br/

IPO date

Jul 19, 2019

Employees

5,260

Domiciled in

Incorporated in

Valuation

Order:

Title BRL in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title BRL in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12
Income
Revenues	2,875,913 23.48%	2,329,057 35.46%	1,719,371 43.14%
Cost of revenue	2,146,001	1,667,141	1,275,540
Unusual Expense (Income)
NOPBT	729,912	661,916	443,831
NOPBT Margin	25.38%	28.42%	25.81%
Operating Taxes	24,166	35,677	31,179
Tax Rate	3.31%	5.39%	7.02%
NOPAT	705,746	626,239	412,652
Net income	386,324 3.41%	373,569 67.28%	223,326 -23.54%
Dividends
Dividend yield
Proceeds from repurchase of equity	(12,369)	(152,317)	(213,722)
BB yield	0.62%	10.84%	14.46%
Debt
Debt current	216,150	239,837	168,153
Long-term debt	3,333,763	3,244,290	2,707,619
Deferred revenue
Other long-term liabilities	423,708	568,927	687,348
Net debt	2,945,049	2,337,138	2,078,733
Cash flow
Cash from operating activities	1,043,623	843,899	630,867
CAPEX	(118,435)	(297,024)	(276,800)
Cash from investing activities	(1,143,051)	(591,469)	(1,274,052)
Cash from financing activities	(439,943)	92,942	364,678
FCF	561,612	477,573	8,613
Balance
Cash	553,030	1,093,082	748,562
Long term investments	51,834	53,907	48,477
Excess cash	461,068	1,030,536	711,070
Stockholders' equity	1,421,889	1,179,761	777,304
Invested Capital	6,280,996	5,460,779	5,099,619
ROIC	12.02%	11.86%	9.24%
ROCE	10.83%	10.20%	7.64%
EV
Common stock shares outstanding	90,537	89,937	94,103
Price	21.93 40.40%	15.62 -0.57%	15.71 -37.91%
Market cap	1,985,473 41.33%	1,404,809 -4.98%	1,478,363 -37.60%
EV	4,972,029	3,793,267	3,608,965
EBITDA	1,019,423	868,136	598,051
EV/EBITDA	4.88	4.37	6.03
Interest	386,296	288,652	175,649
Interest/NOPBT	52.92%	43.61%	39.58%